BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12749221)

  • 1. Resected case of a double cancer, a hepatocellular carcinoma and a cholangiocellular carcinoma, and their spread to the skin.
    Suzuki H; Kuwano H; Masuda N; Hashimoto S; Saitoh T; Kanoh K; Nomoto K; Shimura T
    Hepatogastroenterology; 2003; 50(50):362-5. PubMed ID: 12749221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma.
    Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Kubo S; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2002; 49(46):1083-6. PubMed ID: 12143207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronously resected double primary hepatic cancers - hepatocellular carcinoma and cholangiolocellular carcinoma.
    Matsuda M; Hara M; Suzuki T; Kono H; Fujii H
    J Hepatobiliary Pancreat Surg; 2006; 13(6):571-6. PubMed ID: 17139434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A resected case of a small hepatocellular carcinoma developing within the bile duct.
    Yasui O; Sato T; Andoh H; Kurokawa T; Watanabe D; Sageshima M; Nanjo H
    J Hepatobiliary Pancreat Surg; 2004; 11(3):193-6. PubMed ID: 15235893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double primary liver cancer (intrahepatic cholangiocarcinoma and hepatocellular carcinoma) in a patient with hepatitis C virus-related cirrhosis.
    Inaba K; Suzuki S; Sakaguchi T; Kobayasi Y; Takehara Y; Miura K; Baba S; Nakamura S; Konno H
    J Hepatobiliary Pancreat Surg; 2007; 14(2):204-9. PubMed ID: 17384916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients.
    Nagafuchi Y; Okamoto K; Shono M; Higure A; Todoroki H; Itoh H; Takeda S; Katumoto F; Toyoshima S
    Hepatogastroenterology; 1998; 45(20):523-7. PubMed ID: 9638442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent occurrence of hepatocellular and cholangiocellular cancer nodules in the liver.
    Furuta T; Kanematsu T; Sonoda T; Sugimachi K
    Eur J Surg Oncol; 1987 Feb; 13(1):69-73. PubMed ID: 3028868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of hepatocellular and cholangiocellular carcinoma in different hepatic lobes.
    Ito Y; Fujioka H; Matsuzaki S; Yamamoto O; Okudaira S; Azuma T; Furui J; Kanematsu T
    Hepatogastroenterology; 2003; 50(49):65-8. PubMed ID: 12629992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double cancer in different hepatic lobes: hepatocellular and cholangiocellular carcinoma.
    Ohwada S; Yoshihiro O; Iwazaki S; Tanahashi Y; Sawada T; Takeyoshi I; Kawashima Y; Nakaura S; Iino Y; Morishita Y
    Hepatogastroenterology; 1995; 42(4):411-4. PubMed ID: 8586379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A resected case of combined hepatocellular carcinoma and cholangiocarcinoma associated with cystic formation.
    Utsunomiya T; Saitsu H; Saku M; Takeshita M; Yoshida K; Kajiyama K; Sugimachi K
    Hepatogastroenterology; 2000; 47(33):851-4. PubMed ID: 10919046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double cancer, cholangiocellular and hepatocellular carcinomas, in the cirrhotic liver.
    Yoshikawa T; Hirota S; Matsumoto S; Izaki K; Fukuda T; Sugimura K; Maeda S; Kitagaki H
    Radiat Med; 2002; 20(1):33-6. PubMed ID: 12002601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic recurrence of cholangiolocellular carcinoma: report of a case.
    Yamamoto M; Takasaki K; Nakano M; Saito A
    Hepatogastroenterology; 1996; 43(10):1046-50. PubMed ID: 8884337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mixed hepatocellular carcinoma and cholangiocarcinoma: dual expression of biliary-type cytokeratin and hepatocyte specific marker.
    Tanaka S; Hirohashi K; Uenishi T; Yamamoto T; Hamba H; Kubo S; Tanaka H; Shuto T; Ogawa M; Kinoshita H
    Hepatogastroenterology; 2004; 51(57):839-41. PubMed ID: 15143930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatitis C liver cirrhosis: report of a case.
    Ishida M; Seki K; Tatsuzawa A; Katayama K; Hirose K; Azuma T; Imamura Y; Abraham A; Yamaguchi A
    Surg Today; 2003; 33(3):214-8. PubMed ID: 12658390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers.
    Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Ogawa M; Kubo S; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2002; 49(46):1092-4. PubMed ID: 12143210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy].
    Hayashi H; Beppu T; Ishiko T; Mizumoto T; Masuda T; Okabe K; Baba Y; Okabe H; Takamori H; Kanemitsu K; Hiroto M; Baba H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1941-3. PubMed ID: 17212153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.